Ligand Pharmaceuticals Inc (LGND)
Cash Conversion Ratio
0.49×
Quarterly · Period ending:
LGND Cash Conversion Ratio
Latest reported0.49×period ending
Latest reported0.49×period ending
LGND Quarterly Cash Conversion Ratio (0.43× → 0.49×)
Latest values, visible window
High-resolution chart · PNG
LGND cash conversion ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash Conversion Ratio |
|---|---|
| 0.4946× | |
| -3.6315× | |
| 1.0235× | |
| 0.1115× | |
| 3.215× | |
| 0.6061× | |
| -0.8929× | |
| -3.1078× | |
| -0.2153× | |
| 0.2158× | |
| 0.3683× | |
| -0.6969× | |
| -0.1245× | |
| 0.7517× | |
| -2.9363× | |
| 37.6238× | |
| -5.9106× | |
| -3.0638× | |
| -4.6985× | |
| 1.3301× | |
| 0.5072× | |
| 0.4059× | |
| -0.6806× | |
| -1.598× | |
| 1.0681× | |
| -0.7013× | |
| 1.3431× | |
| 0.4063× | |
| 4.2346× | |
| 0.0679× | |
| -0.5105× | |
| 0.402× | |
| 1.0066× | |
| 1.3198× | |
| -4.1903× | |
| 3.279× | |
| 1.6959× | |
| 3.7679× | |
| -6.1453× | |
| 25.368× | |
| 1.4388× | |
| 1.1244× | |
| 1.8609× | |
| 0.046× | |
| 0.2369× | |
| 5.7321× | |
| 1.089× | |
| 2.7094× | |
| 2.4893× | |
| 0.4545× | |
| 5.9021× | |
| -0.287× | |
| 0.5328× | |
| 1.3652× | |
| -5.4929× | |
| 6.6082× | |
| 0.4296× | |
| -0.3425× | |
| 1.2823× | |
| 0.2985× | |
| 8.802× | |
| 0.0941× | |
| 0.0167× | |
| 0.6484× | |
| 12.7244× | |
| 5.7935× | |
| -0.4196× | |
| -6.4104× | |
| -1.705× | |
| 4.7566× | |
| -0.0884× | |
| 0.7458× | |
| 0.6471× | |
| 2.4396× | |
| -1.4917× | |
| -11.4335× | |
| -163.5635× | |
| -0.1656× | |
| -0.596× | |
| 1.9399× | |
| 0.4343× | |
| 0.1418× | |
| -4.3365× | |
| 4.3605× | |
| 0.9472× | |
| 0.1729× | |
| -2.4806× | |
| 1.1572× | |
| 0.8937× | |
| 0.3477× | |
| 1.2845× | |
| 0.3073× | |
| -0.2708× | |
| 0.4914× | |
| 1.463× | |
| 0.601× | |
| 1.0256× | |
| 0.2488× | |
| 0.2998× | |
| 0.9229× |